4//SEC Filing
Shiff Susan Ph.D. 4
Accession 0001415889-25-011112
CIK 0001346830other
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 5:15 PM ET
Size
5.8 KB
Accession
0001415889-25-011112
Insider Transaction Report
Form 4
Shiff Susan Ph.D.
Director
Transactions
- Award
Stock Option (right to buy)
2025-04-17+12,000→ 12,000 totalExercise: $17.04Exp: 2035-04-16→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest and become exercisable over three years in 12 equal quarterly installments commencing on July 17, 2025, subject to the Reporting Person's continuous service through each applicable vesting date.
Documents
Issuer
Tvardi Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001811463
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 5:15 PM ET
- Size
- 5.8 KB